Alaunos Therapeutics, Inc. (TCRT) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time TCRT price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 47.2 Neutral
Market Cap $48.8M
Volume 2.5K
Fundamentals — 10-Q Q1 2026
Revenue $0
Net Income $-1.0M
EPS $-0.59
P/E Ratio -3.4x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Vieser Jaime | Director | Sell | 3,000 | $2.01 | $6,022 | 2024 Dec 31 |
| Boyle Kevin S. Sr. | Chief Executive Officer | Sell | 68,014 | $0.14 | $9,522 | 2023 Sep 1 |
| Postma Robert W | Director | Buy | 750,000 | $0.65 | $487,500 | 2022 Nov 29 |
| Vieser Jaime | Director | Buy | 1,250,000 | $0.65 | $812,500 | 2022 Nov 29 |
Other Pharmaceutical Stocks
Take TCRT further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put TCRT in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Alaunos Therapeutics, Inc. next reports.
Set alerts on TCRT
Get notified when Alaunos Therapeutics, Inc. hits your price targets or technical conditions are met.
Get Started Free